Luskin, M., Keating, J., Frost, B., Flamand, Y., Garcia, J., Stone, R., Leonard, R., Jaeckle, S., Weizer, C., Lee, J., Galinsky, I., Ryan, J., Winer, E., Chen, E., Letai, A., Murakami, M., Deangelo, D. (2025). Venetoclax plus inotuzumab ozogamicin for relapsed and refractory ALL: Results of a phase I trial. Blood. https://doi.org/10.1182/blood-2025-645